Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer’s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study

被引：0
|
作者：
Caterina Motta
Martina Gaia Di Donna
Chiara Giuseppina Bonomi
Martina Assogna
Agostino Chiaravalloti
Nicola Biagio Mercuri
Giacomo Koch
Alessandro Martorana
机构：
[1] UOSD Centro Demenze,Experimental Neuropsychophysiology Laboratory
[2] University of Rome “Tor Vergata”,Department of Biomedicine and Prevention
[3] IRCCS Santa Lucia Foundation,Human Physiology Unit, Department of Neuroscience and Rehabilitation
[4] University of Rome Tor Vergata,undefined
[5] Istituto Neurologico Mediterraneo,undefined
[6] University of Ferrara,undefined
来源：
Alzheimer's Research & Therapy | / 15卷
关键词：
Alzheimer’s disease; Cerebrospinal fluid biomarkers; Amyloid beta 40; Amyloid beta 42; Amyloid beta 42/40 ratio; Phosphorylated-tau; Fluorodeoxyglucose-positron emission tomography;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Is plasma amyloid-β 1–42/1–40 a better biomarker for Alzheimer’s disease than AβX–42/X–40?
    Hans-Wolfgang Klafki
    Barbara Morgado
    Oliver Wirths
    Olaf Jahn
    Chris Bauer
    Hermann Esselmann
    Johannes Schuchhardt
    Jens Wiltfang
    Fluids and Barriers of the CNS, 19
  • [22] Evaluation of the Cerebrospinal Fluid Amyloid-β1-42/Amyloid-β1-40 Ratio Measured by Alpha-LISA to Distinguish Alzheimer's Disease from Other Dementia Disorders
    Nutu, Magdalena
    Zetterberg, Henrik
    Londos, Elisabet
    Minthon, Lennart
    Nagga, Katarina
    Blennow, Kaj
    Hansson, Oskar
    Ohrfelt, Annika
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2013, 36 (1-2) : 99 - 110
  • [23] Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study
    Dumurgier, Julien
    Schraen, Susanna
    Gabelle, Audrey
    Vercruysse, Olivier
    Bombois, Stephanie
    Laplanche, Jean-Louis
    Peoc'h, Katell
    Sablonniere, Bernard
    Kastanenka, Ksenia V.
    Delaby, Constance
    Pasquier, Florence
    Touchon, Jacques
    Hugon, Jacques
    Paquet, Claire
    Lehmann, Sylvain
    ALZHEIMERS RESEARCH & THERAPY, 2015, 7
  • [24] Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study
    Julien Dumurgier
    Susanna Schraen
    Audrey Gabelle
    Olivier Vercruysse
    Stéphanie Bombois
    Jean-Louis Laplanche
    Katell Peoc’h
    Bernard Sablonnière
    Ksenia V Kastanenka
    Constance Delaby
    Florence Pasquier
    Jacques Touchon
    Jacques Hugon
    Claire Paquet
    Sylvain Lehmann
    Alzheimer's Research & Therapy, 7
  • [25] NEURONORMA Cognitive Battery Associations with Cerebrospinal Fluid Amyloid-β and Tau Levels in the Continuum of Alzheimer's Disease
    Garcia-Escobar, Greta
    Puig-Pijoan, Albert
    Puente-Periz, Victor
    Fernandez-Lebrero, Aida
    Maria Manero, Rosa
    Navalpotro-Gomez, Irene
    Suarez-Calvet, Marc
    Grau-Rivera, Oriol
    Contador-Munana, Jose
    Cascales-Lahoz, Diego
    Duran-Jorda, Xavier
    Boltes, Nuncia
    Claustre Pont-Sunyer, Maria
    Ortiz-Gil, Jordi
    Carrillo-Molina, Sara
    Dolores Lopez-Villegas, Maria
    Teresa Abellan-Vidal, Maria
    Isabel Martinez-Casamitjana, Maria
    Jose Hernandez-Sanchez, Juan
    Padros-Fluvia, Anna
    Pena-Casanova, Jordi
    Sanchez-Benavides, Gonzalo
    JOURNAL OF ALZHEIMERS DISEASE, 2023, 92 (04) : 1303 - 1321
  • [26] Lower Cerebrospinal Fluid Amyloid-β42 Predicts Sooner Time to Antipsychotic Use in Alzheimer's Disease
    Cahan, Joshua G.
    Vassar, Robert
    Bonakdarpour, Borna
    JOURNAL OF ALZHEIMERS DISEASE REPORTS, 2023, 7 (01) : 641 - 647
  • [27] A method for the detection of amyloid-β1-40, amyloid-β1-42 and amyloid-β oligomers in blood using magnetic beads in combination with flow cytometry and its application in the diagnostics of Alzheimer's disease
    Santos, Alexander Navarrete
    Simm, Andreas
    Holthoff, Vjera
    Boehm, Gerald
    JOURNAL OF ALZHEIMERS DISEASE, 2008, 14 (02) : 127 - 131
  • [28] Evaluation of the diagnostic quality of Alzheimer's disease after including the amyloid-β 42/40 ratio as a biomarker
    Lopez Mesa, C.
    Romero Fabrega, J.
    Iglesias Espinosa, M.
    Vilchez Carrillo, R.
    Carnero Pardo, C.
    Carrera Munoz, I.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 144 - 144
  • [29] Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease
    Janelidze, Shorena
    Teunissen, Charlotte E.
    Zetterberg, Henrik
    Allue, Jose Antonio
    Sarasa, Leticia
    Eichenlaub, Udo
    Bittner, Tobias
    Ovod, Vitaliy
    Verberk, Inge M. W.
    Toba, Kenji
    Nakamura, Akinori
    Bateman, Randall J.
    Blennow, Kaj
    Hansson, Oskar
    JAMA NEUROLOGY, 2021, 78 (11) : 1375 - 1382
  • [30] Increased Total Tau But Not Amyloid-β42 in Cerebrospinal Fluid Correlates with Short-Term Memory Impairment in Alzheimer's Disease
    Lin, Yuh-Te
    Cheng, Jiin-Tsuey
    Yao, Yun-Chin
    Juo, Liang-I
    Lo, Yuk-Keung
    Lin, Ching-Hwung
    Ger, Luo-Ping
    Lu, Pei-Jung
    JOURNAL OF ALZHEIMERS DISEASE, 2009, 18 (04) : 907 - 918
12345